Krista L. Lanctôt, executive director
view scientist profile

Dr. Krista L. Lanctôt is a pharmacologist. She received her PhD from the department of pharmacology, University of Toronto (U of T), in 1998, and has additional training in pharmacoepidemiology and neuroimaging. She is a senior scientist in the Hurvitz Brain Sciences Research Program at Sunnybrook Research Institute (SRI) and an associate professor in the departments of psychiatry and pharmacology at the University of Toronto.

Dr. Lanctôt is an active researcher in outcomes research, particularly in clinical neuropharmacology. Her main areas of research are the neuropsychopharmacology of Alzheimer’s disease and related disorders, and pharmacotherapy of neuropsychiatric symptoms associated with other central nervous system disorders such as traumatic brain injury and stroke. She teaches psychopharmacology at the undergraduate and graduate levels through her appointment at the U of T.

Nathan Herrmann, core consultant
view scientist profile

Dr. Nathan Herrmann received his MD degree from U of T in 1983 and his FRCP(C) in 1988. He is a full professor in psychiatry at U of T and an associate scientist at SRI. In addition, he is head of the division of geriatric psychiatry at Sunnybrook Health Sciences Centre, where he is also appointed to the department of medicine (clinical pharmacology), and chairs the pharmacy and therapeutics committee for the hospital.

Dr. Herrmann has made major contributions to outcomes research in the areas of the clinical pharmacology of dementia (treatment of behavioural disturbances and cognition), post-stroke depression and the pharmacotherapy of late-life affective disorders. He has published numerous studies on the pharmacotherapy of behavioural disturbances in dementia that involve the use of novel agents and that attempt to determine the underlying neurobiology of these disorders. He has participated in a number of studies on post-stroke depression, examining its neuroimaging correlates. He has also published studies, reviews (including meta-analyses) and guidelines on the management of depression and bipolar illness in late life, and has participated in psychopharmacology projects on drug interactions, adverse events and phamacoeconomics.

Anthony Levitt, core consultant
view scientist profile

Dr. Anthony Levitt graduated from medical school in western Australia and came to Canada to train in psychiatry in 1985. He completed his research training as a fellow with Dr. Russell Joffe in 1990. Since then, he has been the director of mood disorders programs at the Centre for Addiction and Mental Health, McMaster University and, more recently, Sunnybrook. He is the chief of the Hurvitz Brain Sciences Program at Sunnybrook. He is also a full professor in the department of psychiatry at U of T and a scientist at SRI.

Dr. Levitt’s area of research and clinical interest is mood disorders. He has published scientific articles on treatment-resistant depression and bipolar disorder, treatment of adolescent depression, treatment of seasonal depression, and the role of thyroid hormones and folate in the treatment of depression. He is chair of the Canadian Institutes of Health Research randomized clinical trials committee, and is past president of the International Society for Light Therapy and Biological Rhythms.

Paul Oh, core consultant

Dr. Paul Oh is the medical director of the cardiac rehab and secondary prevention program at the Toronto Rehabilitation Institute. He received his MD from U of T in 1988, and completed training in internal medicine and clinical pharmacology in Toronto with a focus in the management and evaluation of cardiac risk factors, economic evaluation of health care technologies and clinical epidemiology. He has training and extensive experience in health economics and outcomes research. He is a staff physician in the department of medicine at Sunnybrook in the divisions of clinical pharmacology and general internal medicine. He is the former chair of the provincial drug quality and therapeutics committee that is advisory to the drug programs branch of the Ontario Ministry of Health and Long-Term Care.

Abby Li, research assistant

Abby Li received her Honours B.Sc. in biology and psychology from Queen's University in 2005 and M.Sc. in biology from the University of Waterloo in 2008. She works with Drs. Lanctôt and Herrmann as the study coordinator of a large-scale prospective study of patients across Canada. She is also the study coordinator of clinical studies exploring the management and treatment of Alzheimer's disease, and is involved in research examining mood and memory in coronary artery disease and stroke.

Sophie Wong, research assistant

Sophie Wong is a professional experience year student from the University of Toronto. She is in her fourth year of an Honours B.Sc., completing a dual specialist program in pharmacology and toxicology. She conducts research in pharmacoeconomics through data analysis of prospective studies and is involved in patient recruitment for clinical research studies.